Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × naxitamab × CNS × Clear all

Status

Sponsor Class

Study Type

Interventional 13 Observational 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 1

Interventions

Radiotherapy 21 Surveys and Questionnaires 20 Magnetic Resonance Spectroscopy 20 Blood Specimen Collection 18 Radiosurgery 15 Temozolomide 12 Magnetic Resonance Imaging 12 Surgical Procedures, Operative 10 Neuropsychological Tests 10 Radiation 8 Polymerase Chain Reaction 8 Amplified Fragment Length Polymorphism Analysis 8 Immunohistochemistry 7 Gene Expression Profiling 6 Phlebotomy 5 Observation 5 Flow Cytometry 5 Microarray Analysis 4 Mental Status and Dementia Tests 4 Interviews as Topic 4 Biopsy 4 gadobenic acid 3 Transurethral Resection of Bladder 3 Radiotherapy, Intensity-Modulated 3 Quality of Life 3 Physical Examination 3 Perfusion Magnetic Resonance Imaging 3 In Situ Hybridization, Fluorescence 3 Genetic Testing 3 Diffusion Tensor Imaging 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06574698 2024-08-28

Adding Of Naxitamb In Induction Therapy For High Risk Neuroblastoma

Guangzhou Women and Children's Medical Center

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡